Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
biotech
boston
boston blog main
clinical trials
life sciences
national blog main
akouos
archive
astellas pharmaceuticals
biotech ipos
boston top stories
california institute for biomedical research
coronavirus
deals
decibel therapeutics
dyne therapeutics
frequency therapeutics
government
harvard university
hearing loss
investing
jeffrey karp
medical
metacrine
multiple sclerosis
myotonic dystrophy type 1
nonalcoholic steatohepatitis
perceptive life sciences
rare disease drugs
rare diseases
regenerative medicine
robert langer
salk institute
san diego blog main
san diego top stories
san francisco blog main
sensorineural hearing loss
taiwania capital management
the scripps research institute
What
developing
3
×
drug
3
×
fda
ipo
medicines
therapeutics
administration
affects
americans
approved
authorized
authorizes
booster
brings
company
covid
date
disorders
dyne
dyne’s
food
frequency
genetic
greater
hearing
loss
meds
million
millions
muscle
muscular
officially
people
plans
preclinical
raised
rare
regenerative
risk
select
Language
unset
Current search:
developing
×
fda
×
drug
×
@slashgear.com
2 years ago
FDA authorizes COVID-19 booster shot, but only for some people
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
